Michael, who has 30 years of litigation experience, frequently advises corporations on the strategic use of intellectual property assets, post grant review, licensing programs, the Hatch-Waxman Act, and patent due diligence issues. He also has litigated emergency injunction proceedings involving pharmaceuticals and medical devices, computer software, trademark counterfeiting, and industrial espionage.

Michael has been involved with a variety of technologies, including renal, infusion, and pulmonary devices; medical diagnostic systems; pharmaceuticals; biosimilars, image-processing systems; cellular networks; computer chips; microprocessing clocking; geographical information systems; vehicle tracking systems; network verification systems; stem cells; power tools; crude oil desalting; metrology systems; paper chemistry; security systems; automobile braking, steering, and sensor systems; network management software programs; computer interfaces; progressive gaming systems; and Internet-based business methods.